Bonus Biogroup Ltd.
Long
Atualizado

TASE:BONS

140
Oramed Pharm - is a clinical stage biopharmaceutical company.

2022/3 Planned launch of MesenCure multinational phase III clinical trial; and phase II/III clinical trial in the US evaluating the safety and efficacy of BonoFillTM injectable live bone graft for bone regeneration.
Nota
It's Bonus Biogroup, of course! Wrong company name in description was mistakenly copy-pasted (!)

Aviso legal

As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.